Stereotaxis Inc. (AMEX:STXS) shares fell to a low of $7.40 before closing at $7.51. Intraday shares traded counted 0.43 million, which was -24.85% lower than its 30-day average trading volume of 345.66K. STXS’s previous close was $7.81 while the outstanding shares total 74.97M. The firm has a beta of 1.57. The stock’s Relative Strength Index (RSI) is 56.65, with weekly volatility at 5.88% and ATR at 0.42. The STXS stock’s 52-week price range has touched low of $3.03 and a $8.62 high. The stock traded lower over the last trading session, losing -3.84% on 05/27/21.
Investors have identified the Medical Instruments & Supplies company Stereotaxis Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $555.74 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Stereotaxis Inc. (STXS) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 56.54 million total, with 16.69 million as their total liabilities.
STXS were able to record -0.34 million as free cash flow during the 08/12/2021 quarter of the year, this saw their quarterly net cash flow reduce by 58000.0. In cash movements, the company had a total of -0.3 million as operating cash flow.
Potential earnings growth for Stereotaxis Inc. (STXS)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 08/12/2021 quarter of the year, Stereotaxis Inc. recorded a total of 8.62 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 33.25% coming in sequential stages and their sales for the 08/12/2021 quarter increasing by 20.85%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 2.61 million trying to sell their products during the last quarter, with the result yielding a gross income of 6.02 million. This allows shareholders to hold on to 74.97M with the recently reported earning now reading -0.02 cents per share. This is a figure that compared to analyst’s prediction for their 08/12/2021 (-0.02 cents a share).
Having a look at the company’s valuation, the company is expected to record -0.04 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on STXS sounds very interesting.
Is the stock of STXS attractive?
In related news, 10% Owner, Isaac Paul J sold 14,927 shares of the company’s stock in a transaction that recorded on Sep 16. The sale was performed at an average price of 4.15, for a total value of 61,947. As the sale deal closes, the Director, Benfer David now sold 4,999 shares of the company’s stock, valued at 21,696. Also, 10% Owner, Isaac Paul J sold 100 shares of the company’s stock in a deal that was recorded on Jul 23. The shares were price at an average price of 4.10 per share, with a total market value of 410. Following this completion of acquisition, the 10% Owner, Isaac Paul J now holds 5,200 shares of the company’s stock, valued at 21,476. In the last 6 months, insiders have changed their ownership in shares of company stock by 2.60%.
4 out of 4 analysts covering the stock have rated it a Buy, while 0 have maintained a Hold recommendation on Stereotaxis Inc.. 0 analysts has assigned a Sell rating on the STXS stock. The 12-month mean consensus price target for the company’s shares has been set at $9.33.